Abstract
Since Willem Kolff, Nils Alwall and other pioneers performed the first regular dialysis treatments on uremic patients in the 1940s, dialysis membranes have been under continual development with respect to improved functionality and biocompatibility. Bulky ‘plate kidneys’ which were used in the early days of clinical hemodialysis have nowadays been replaced by highly optimized disposable membrane devices containing state of the art synthetic hollow fiber membranes in combination with sophisticated volume-balancing dialysis machines.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
G. Lonnemann, J. Flöge, R. Schindler, T. Behme, B. Lenzner, S. Shaldon, and K.M. Koch, 1989, Passage of cytokine E-coli fragments (CEF) through various hemodialysis (HD) membranes, Kidney Int 35:354.
C.A. Dinarello, G. Lonnemann, R. Maxwell, and S. Shaldon, 1987, Ultrafiltration to reject human interleucin-1-inducing substances derived from bacterial cultures, J. Clin. Microbiol 25:1233–1238.
H. Strathmann, and H. Göhl, 1990, Membranes for blood purification: state of the art and new developments, Contrib. Nephrol 78:119–141.
H. Göhl, R. Buck, and H. Strathmann, 1992, Basic features of the polyamide membranes, in: The evolution of a synthetic membrane for renal therapy, Contrib. Nephrol, Volume 96 (S. Shaldon, and K.M. Koch, eds.), pp. 1–25, Karger, Basel.
J. Flöge, C. Granolleras, G. Deschodt, M. Heck, G. Baudin, B. Branger, O. Tournier, B. Reinhard, G.M. Eisenbach, L.C. Smeby, K.M. Koch, and S. Shaldon, 1989, High-flux synthetic versus cellulosic membranes for β2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration, Nephrol Dial. Transplant 4:653–657
H. Göhl, C.M. Bell, R. Buck, R. Deppisch, H. Straatman, and M. Pirner, 1992, Visualization and measurement of microdomains in polyamide dialysis membranes: Optimized size facilitates performance and biocompatibility, Blood Purif 10(2):86.
F. Gejyo, S. Odani, T. Yamada, N. Honma, H. Saito, Y. Suzuki, Y. Nakagawa, H. Kobayashi, Y. Maruyama, Y. Hirasawa, M. Suzuki, and M. Arakawa, 1986, β2-microglobulin: A new form of amyloid protein associated with chronic hemodialysis, Kidney Int 30:385–390.
N. Braun, S. Rosenfeld, M. Giolai, W. Banzhaf, R. Fretschner, H. Warth, C. Weinstock, R. Deppisch, C.M. Erley, G. A. Müller, and T. Risler, 1995, Effect of continuous hemodiafiltration on IL-6, TNF-α, C3a, and patients with SIRS/septic shock using two different membranes, in:. Continuous extracorporeal treatment in multiple organ dysfunction syndrome, Contrib. Nephrol, Volume 116 (H.G. Sieberth, H.K. Stummvoll, and H. Kierdorf, eds.), pp. 89–98, Karger, Basel.
E. Klein, F.F. Holland, A. Donnaud, A. Lebeouf, and K. Eberle, 1977, Diffusive and hydraulic permeabilities of commercially available cellulosic hemodialysis films and hollow fibers, J. Membr. Sci 2:349–364.
S. Zitta, A. Mauric, J. Roob, and H. Hölzer, 1995, Clinical evaluation of polyflux dialyzer membranes, Blood Purif 13:28–29.
R. Deppisch, M. Betz, G.M. Hänsch, E.W. Rauterberg, and E. Ritz, 1992, Biocompatibility of the polyamide membranes, in: The evolution of a synthetic membrane for renal therapy, Contrib. Nephrol, Volume 96 (S. Shaldon, and K.M. Koch, eds.), pp. 26–46, Karger, Basel.
R. Deppisch, E. Ritz, G.M. Hänsch, M. Schöls, and E.W. Rauterberg, 1994, Biocompatibility-perspectives in 1993, Kidney Int 45(S44):77–84.
R. Deppisch, U. Haug, H. Göhl, and E. Ritz, 1994, Role of proteinase/antiproteinase inhibitor disequilibrium in the bioincompatibility induced by artificial surfaces, Nephrol. Dial Transplant 3(suppl): 17–23.
C. Combe, M. Pourtein, V. de Précigout, A. Baquey, D. Morel, L. Potaux, P. Vincendeau, J.H. Bézian, and M. Aparicio, 1994, Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high flux biocompatible membrane, Am. J. Kid. Dis 24(3):437–42.
M. Haag-Weber, B. Mai, R. Deppisch, H. Goehl, and W.H. Hoerl, 1994, Studies on biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate, Clin. Nephrol 41:245–251.
P.R. Craddock, D. Hammerschmidt, J. White, A.P. Dalmasso, and H.S. Jacob, 1977, Complement (C5a)-induced granylocyte aggregation in vitro: a possible mechanism of complement mediated leucostasis and leucopenia, J. Clin. Invest 60:260–263.
L.S. Kaplow, and J.A. Goffinet, 1968, Profound neutropenia during early phase of hemodialysis, J. Am. Med. Ass 203:1135–1137.
H. Sperschneider, G. Steiner, R. Dietrich, R. Deppisch, and G. Stein, 1997, Reduced thrombogenic activity and heparin consumption in extracorporeal blood purification circuits: in-vivo study with microdomain-modified surfaces, Blood Purif 15(S2):47.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Storr, M., Deppisch, R., Buck, R., Goehl, H. (1998). The Evolution of Membranes for Hemodialysis. In: Hıncal, A.A., Kaş, H.S. (eds) Biomedical Science and Technology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5349-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5349-6_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7440-4
Online ISBN: 978-1-4615-5349-6
eBook Packages: Springer Book Archive